Literature DB >> 21770929

Chronic migraine, classification, differential diagnosis, and epidemiology.

Richard B Lipton1.   

Abstract

Chronic migraine (CM) is the most disabling of the 4 types of primary chronic daily headache (CDH) of long duration, a syndrome defined by primary headaches 15 or more days per month for at least 3 months with attacks that last 4 hours or more per day on average. CDH of long duration includes CM, chronic tension-type headache, new daily persistent headache, and hemicrania continua. CM affects approximately 2% of the adult population in Western countries, imposing substantial burdens on individual sufferers and their families and, more broadly, upon society. Although this disorder is highly disabling and prevalent, it remains largely underdiagnosed and undertreated. Diagnosing CM requires a systematic approach that includes these steps: (1) exclude a secondary headache disorder, and (2) diagnose a specific primary headache syndrome based on frequency and duration, for example, short-duration episodic, long-duration episodic, or long-duration chronic. CM usually develops as a complication of episodic migraine after a period of increasing headache frequency. This migraine transformation is associated with a number of risk factors, some of which cannot be modified, including age and race. Other risk factors for CM are modifiable, such as obesity, snoring, head injury, stressful life events, and overuse of opioids and barbiturates. However, risk factor modification has not yet been shown to decrease the likelihood of CM onset. According to a cross-sectional analysis of data from the American Migraine Prevalence and Prevention study published this year in Journal of Neurology, Neurosurgery, and Psychiatry, when compared to patients with episodic migraine, patients with CM were significantly less likely to be employed full-time and almost twice as likely to be occupationally disabled. In addition, patients with CM were nearly twice as likely to have anxiety, chronic pain, or depression. Furthermore, patients with CM had higher cardiovascular and respiratory risk, were 40% more likely to have heart disease and angina, and were 70% more likely to have a history of stroke. These findings highlight the paramount importance of clinical vigilance, accurate diagnosis, and appropriate, effective management - including treatment or referrals - to improve patient outcomes.
© 2011 American Headache Society.

Entities:  

Mesh:

Year:  2011        PMID: 21770929     DOI: 10.1111/j.1526-4610.2011.01954.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  32 in total

Review 1.  Nocebo in headaches: implications for clinical practice and trial design.

Authors:  Dimos D Mitsikostas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 2.  Peripheral neuromodulation in chronic migraine.

Authors:  F Perini; A De Boni
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 3.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 4.  Chronic daily headache in the elderly.

Authors:  Aynur Özge
Journal:  Curr Pain Headache Rep       Date:  2013-12

5.  Endonasal mucosal contact points in chronic migraine.

Authors:  V Ferrero; G Allais; S Rolando; T Pozzo; R Allais; C Benedetto
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 6.  The Face of Chronic Migraine Which Has Started to be Clarified.

Authors:  Zeynep Aydin Özemir; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 7.  OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

8.  Experience of Botulinum Toxin A Injections for Chronic Migraine Headaches in a Pediatric Chronic Pain Clinic.

Authors:  Lisgelia Santana; Cherry Liu
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

Review 9.  A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.

Authors:  Amaal J Starling; Bert B Vargas
Journal:  Curr Pain Headache Rep       Date:  2015-10

10.  Opioid pharmacotherapy for chronic noncancer pain: the american experience.

Authors:  C Richard Chapman
Journal:  Korean J Pain       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.